Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Roman A Blaheta"'
Autor:
Berlise Yengwa Bakam, Romeo Urich Fosso, Timothy Grein, Derek Tantoh Ndinteh, Sebastian Maxeiner, Stéphane Zingue, Roman A Blaheta, Dieudonne Njamen
Publikováno v:
Journal of Functional Foods, Vol 114, Iss , Pp 106088- (2024)
Pumpkin seeds are claimed to treat prostate tumour/cancer. The in vitro (ability to inhibit cell growth through MTT assay) and in vivo (ability to prevent testosterone-induced BPH in rats at the doses of 125, 250, 500 and 1000 mg/kg BW) of six edible
Externí odkaz:
https://doaj.org/article/ef768c7df15b4f42bb8cc1b9b25e80c6
Autor:
Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Igor Tsaur, Karen Nelson, Jesco Pfitzenmaier, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110244 (2014)
The cyanogenic diglucoside amygdalin, derived from Rosaceae kernels, is employed by many patients as an alternative anti-cancer treatment. However, whether amygdalin indeed acts as an anti-tumor agent is not clear. Metastasis blocking properties of a
Externí odkaz:
https://doaj.org/article/4e7b1e1d6d834da0a331c8ebd3a0f7a0
Autor:
Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105590 (2014)
Amygdalin, a natural compound, has been used by many cancer patients as an alternative approach to treat their illness. However, whether or not this substance truly exerts an anti-tumor effect has never been settled. An in vitro study was initiated t
Externí odkaz:
https://doaj.org/article/73bf579315dc4dc8aa9c4d5db748b706
Autor:
Jens Mani, Jasmina Makarević, Eva Juengel, Hanns Ackermann, Karen Nelson, Georg Bartsch, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83709 (2013)
Scientists who are members of an editorial board have been accused of preferentially publishing their scientific work in the journal where they serve as editor. Reputation and academic standing do depend on an uninterrupted flow of published scientif
Externí odkaz:
https://doaj.org/article/4fcb0daef0cb435b8d3d0223b79da4e7
Autor:
Eva Juengel, Jasmina Makarević, Igor Tsaur, Georg Bartsch, Karen Nelson, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53100 (2013)
Targeted drugs have significantly improved the therapeutic options for advanced renal cell carcinoma (RCC). However, resistance often develops, negating the benefit of these agents. In the present study, the molecular mechanisms of acquired resistanc
Externí odkaz:
https://doaj.org/article/f157248cce14428dab16c66fa9c186c0
Autor:
Jens Mani, Jasmina Makarević, Eva Juengel, Hanns Ackermann, Karen Nelson, Axel Haferkamp, Roman A Blaheta
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52420 (2012)
The pathophysiologic mechanisms behind urologic disease are increasingly being elucidated. The object of this investigation was to evaluate the publication policies of urologic journals during a period of progressively better understanding and manage
Externí odkaz:
https://doaj.org/article/efbd05dbb22b4ec09073adb4bcefb14a
Autor:
Eva Juengel, Pascal Schnalke, Jochen Rutz, Sebastian Maxeiner, Felix K.-H. Chun, Roman A. Blaheta
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1630 (2021)
Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors predominate as first-line therapy options for renal cell carcinoma. When first-line TKI therapy fails due to resistance development, an optimal second-line therapy has not yet been es
Externí odkaz:
https://doaj.org/article/d658e594097e425e983507c22ab51534
Autor:
Igor Tsaur, Anita Thomas, Eva Juengel, Sebastian Maxeiner, Timothy Grein, Quynh Chi Le, Veronika Muschta, Jochen Rutz, Felix K. H. Chun, Roman A. Blaheta
Publikováno v:
Biology, Vol 10, Iss 10, p 1007 (2021)
The serum level of soluble (s)E-cadherin is elevated in several malignancies, including prostate cancer (PCa). This study was designed to investigate the effects of sE-cadherin on the behavior of PCa cells in vitro, with the aim of identifying a pote
Externí odkaz:
https://doaj.org/article/4096ec2ba66a4e37835f6aa48dba26ac
Autor:
Hui Xie, Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Anita Thomas, Eva Juengel, Felix K.-H. Chun, Jindrich Cinatl, Axel Haferkamp, Igor Tsaur, Roman A. Blaheta
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4682
Combined cisplatin–gemcitabine (GC) application is standard for treating muscle-invasive bladder cancer. However, since rapid resistance to treatment often develops, many patients turn to supplements in the form of plant-based compounds. Sulforapha
Autor:
Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Marlon Sonnenburg, Salma El Khadir, Nino Makhatelashvili, Johanna Mann, Hui Xie, Jindrich Cinatl, Anita Thomas, Felix K.-H. Chun, Axel Haferkamp, Roman A. Blaheta, Igor Tsaur
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 10996
Combined cisplatin–gemcitabine treatment causes rapid resistance development in patients with advanced urothelial carcinoma. The present study investigated the potential of the natural isothiocyanates (ITCs) allyl-isothiocyanate (AITC), butyl-isoth